Showing 3031-3040 of 18629 results for "".
Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
https://reachmd.com/programs/project-oncology/emerging-metastatic-breast-cancer-therapies-from-cdk-inhibitors-to-serds-and-beyond/26818/Tune in to learn about the emerging therapies for metastatic breast cancer.Interventional COPD Care Reduces Healthcare Visits and Improves Outcomes
https://reachmd.com/programs/clinicians-roundtable/interventional-copd-care-reduces-healthcare-visits-and-improves-outcomes/24555/Explore a study that evaluated a unique approach to detecting and treating patients with undiagnosed COPD or asthma.Insights on Statin Therapy & LDL Cholesterol from the CLEAR Outcomes Trial
https://reachmd.com/programs/acc-action-center/insight-on-statin-therapy-ldl-cholesterol-from-the-clear-outcomes-trial/15063/What did we learn from the CLEAR Outcomes trial, and what do these results mean for nonstatin therapies? Learn more.Lessons in Dermatology Care: Trust Patients’ Intuitions & Ease Fears
https://reachmd.com/programs/dermconsult/lessons-in-dermatology-care-trust-patients-intuitions-ease-fears/12576/As dermatologists, we know the signs of skin cancer, but there are still some lessons we can learn from our patients.You Asked Questions About Coronavirus, Tom Inglesby Answered
https://reachmd.com/programs/public-health-call/you-asked-questions-about-coronavirus-tom-inglesby-answered/11467/Does the virus cause male sterility? Are false negatives a problem with COVID tests? Get these and other FAQs answered.The Commonwealth Fund's Status Report on Health Insurance Coverage Nationwide
https://reachmd.com/programs/conversations-on-health-care/commonwealth-funds-status-report-health-insurance-coverage-nationwide/7292/This week, hosts Mark Masselli and Margaret Flinter speak with Sara Collins, PhD, Vice President of Health Care Coverage and Access at the Commonwealth Fund, a non-partisan foundation dedicated to promoting a high-functioning health care system. Dr. Collins discusses the Fund's recent report showingEnabling Healthcare Reform Using Information Technology
https://reachmd.com/programs/conversations-on-health-care/enabling-healthcare-reform-using-information-technology/6955/This week, Mark and Margaret speak with Dr. Harry Greenspun, M.D., Senior Advisor at the Deloitte Center for Health Solutions (DCHS), part of Deloitte LLP. He has held a diverse range of clinical and executive roles and is now responsible for helping Deloitte's health care, life sciences and governmThe "Upstream" Doctors: Transforming Health Care at its Source
https://reachmd.com/programs/conversations-on-health-care/the-upstream-doctors-transforming-health-care-at-its-source/6816/Hosts Mark Masselli and Margaret Flinter from CHC's Conversations on Health Care program speak with Dr. Rishi Manchanda, Founder and President of HealthBegins, an online portal to link "upstreamists" - health clinicians working on solving the social and environmental determinants of health. He discuHow Epidermolysis Bullosa Treatments Went from Blisters to Breakthroughs
https://practicaldermatology.com/topics/rare-disease/how-epidermolysis-bullosa-treatments-went-from-blisters-to-breakthroughs/54391/Current FDA-approved therapies oleogel-S10, beremagene geperpavec, and prademagene zamikeracel represent major therapeutic breakthroughs for the treatment of epidermolysis bullosa (EB). Earlier systemic intervention, improved nutrition, and proactive management of complications have extended survivAnti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
https://reachmd.com/programs/neurofrontiers/anti-fibrotic-adcs-show-promise-in-muscle-preservation-for-dmd/35684/Based on a recent preclinical study published in iScience, a novel antibody-drug conjugate approach reduces fibrosis and improves muscle function in a Duchenne muscular dystrophy (DMD) mouse model, highlighting its potential for early intervention therapies. Read more about the findings and how they